Active Research Protocols
- 01-I-0202 – Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections
- 12-I-0133 – A Randomized, Double-Blind, Placebo Controlled Study of Liposomal Amikacin for Inhalation (Arikace¨) in Patients with Recalcitrant Nontuberculous Mycobacterial Lung Disease
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014